Physician profile
Nikitha Paluri
NPI 1467804237
$759.82
in general payments reported to CMS, 2019-2025
9 companies · $677 in 2025
The $677 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $55.68 · 2024: $27.22 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $437.93 | 2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $83.72 | 2025 | Repatha, Otezla |
| Lilly USA, LLC | $67.96 | 2025 | Zepbound, Mounjaro, Kisunla |
| Abbvie INC. | $55.68 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.91 | 2025 | |
| Glaxosmithkline, LLC. | $27.22 | 2024 | Shingrix |
| Exact Sciences Corporation | $23.53 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $19.29 | 2025 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $14.58 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikitha Paluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.